Phytoestrogens are plant-derived compounds resembling human estrogen and have
recently gained attention due to their potential role in improving cardiovascular health. These
compounds exert their effects through various mechanisms, including interactions with estrogen
receptors, growth factor receptors, inflammatory mediators, thrombogenic reactions, and apoptotic
pathways. This results in cardioprotective effects like modulating endothelial function, decreasing
vessel tone, reducing inflammation, altering lipid profiles, and influencing arrhythmogenesis.
Recent studies indicate the intricate and multidimensional association between phytoestrogens
and cardiovascular disease. Despite the overwhelming evidence that phytoestrogen intake
lowers the risk of myocardial infarction (MI), prevents atherosclerosis, improves cardiac
function, prevents hypertension, and reduces the risk of arrhythmias, there have been studies that
show contradictory outcomes.
For this reason, the therapeutic use of phytoestrogens for the treatment of cardiovascular diseases,
which appears to be extremely promising, should be handled cautiously, considering the individual
variances, dosage, and the specific components of phytoestrogens. This review consolidates
findings on the effects of phytoestrogens on the heart and blood vessels, explores the
mechanisms behind these interactions, and seeks to determine the best methods for using phytoestrogens
as a supplement in managing and preventing cardiovascular disease. By understanding
these aspects, we can better evaluate the potential of phytoestrogens in cardiovascular health
and develop guidelines for their safe and effective use.